North America Exosomes Market Size & Outlook, 2026-2033
The exosomes market in North America is expected to reach a projected revenue of US$ 476.3 million by 2030. A compound annual growth rate of 30% is expected of North America exosomes market from 2025 to 2030.
In terms of revenue, North America region accounted for 56.6% of the global exosomes market in 2024.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
North America is the fastest growing regional market and is projected to reach USD 476.3 million by 2030.
The introduction of technologically advanced products by North America based firms to improve the workflow efficiency is among factors that contributed to the higher share. For instance, Ontario-based Norgen Biotek launched four new kits for the simple and rapid isolation of exosomes from cell culture media, urine, and plasma.
Significant investments made by several entities in this region for technological advancements in existing techniques to purify and analyze micro vesicles are expected to positively influence the regional market.
Realizing the future potential of exosomes in various sectors, U.S.-based companies are undertaking collaborations within the country with international firms. In addition, companies are filing U.S patent applications for exosome-based projects.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Exosomes Market Outlook will help companies and investors design strategic landscapes.
Kits & Reagents was the largest segment with a revenue share of 58.92% in 2024.
Horizon Databook has segmented the North America exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
The introduction of technologically advanced products by North America based firms to improve the workflow efficiency is among factors that contributed to the higher share. For instance, Ontario-based Norgen Biotek launched four new kits for the simple and rapid isolation of exosomes from cell culture media, urine, and plasma.
Significant investments made by several entities in this region for technological advancements in existing techniques to purify and analyze micro vesicles are expected to positively influence the regional market.
Realizing the future potential of exosomes in various sectors, U.S.-based companies are undertaking collaborations within the country with international firms. In addition, companies are filing U.S patent applications for exosome-based projects.
North America Exosomes Market Workflow Outlook (Revenue, USD Million , 2021-2033)
Isolation Methods
Downstream Analysis
North America Exosomes Market Product Outlook (Revenue, USD Million , 2021-2033)
Kits & Reagents
Instruments
Services
North America Exosomes Market End Use Outlook (Revenue, USD Million , 2021-2033)
Hospitals & diagnostics centers
Pharmaceutical & biotechnology companies
Academic & research institutes
North America Exosomes Market Application Outlook (Revenue, USD Million , 2021-2033)
Neurodegenerative diseases
Cardiovascular diseases
Others
Cancer
Infectious diseases
Reasons to subscribe to Exosomes Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Exosomes Market Outlook databook
Our clientele includes a mix of Exosomes Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Exosomes Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Exosomes Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.